tm
Seeing Is Believing
tm
Seeing Is Believing
Processa Pharmaceuticals's activity chart (see below) currently has 13 price targets and 10 ratings on display.
Analysts average stock forecasts to be materialized ratio is 78.89% with an average time for these price targets to be met of 343.4 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 02-Sep-2025. First documented stock forecast 02-Aug-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-May-2024
$1
$-0.86 (-46.24%)
$2
1 years 14 days ago
(02-Sep-2025)
8/9 (88.89%)
$-3.7 (-78.72%)
235
Hold Since 17-Nov-2023
$2000
2 years 9 months 30 days ago
(17-Nov-2023)
2/3 (66.67%)
$1670 (506.06%)
371
Buy Since 13-May-2022
$1600
$1597.57 (65743.62%)
$180
3 years 5 months 12 days ago
(04-Apr-2023)
1/2 (50%)
$1355 (553.06%)
465
Buy Since 02-Aug-2021
$60
$57.57 (2369.14%)
$160
3 years 5 months 13 days ago
(03-Apr-2023)
4/4 (100%)
$-182.5 (-75.26%)
411
What is PCSA (Processa Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on PCSA (Processa Pharmaceuticals)?
Which analyst has the current lower performing score on PCSA (Processa Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most bullish on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most reserved on PCSA (Processa Pharmaceuticals)?
